These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25231688)

  • 1. The tumor-stroma ratio is an independent predictor for survival in nasopharyngeal cancer.
    Zhang XL; Jiang C; Zhang ZX; Liu F; Zhang F; Cheng YF
    Oncol Res Treat; 2014; 37(9):480-4. PubMed ID: 25231688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma.
    Wang K; Ma W; Wang J; Yu L; Zhang X; Wang Z; Tan B; Wang N; Bai B; Yang S; Liu H; Zhu S; Cheng Y
    J Thorac Oncol; 2012 Sep; 7(9):1457-61. PubMed ID: 22843085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-stroma ratio is an independent predictor for survival in NSCLC.
    Zhang T; Xu J; Shen H; Dong W; Ni Y; Du J
    Int J Clin Exp Pathol; 2015; 8(9):11348-55. PubMed ID: 26617859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.
    Peng H; Chen L; Zhang Y; Guo R; Li WF; Mao YP; Tan LL; Sun Y; Zhang F; Liu LZ; Tian L; Lin AH; Ma J
    Oncotarget; 2016 Apr; 7(17):24208-16. PubMed ID: 27008701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-stroma ratio is an independent predictor for survival in early cervical carcinoma.
    Liu J; Liu J; Li J; Chen Y; Guan X; Wu X; Hao C; Sun Y; Wang Y; Wang X
    Gynecol Oncol; 2014 Jan; 132(1):81-6. PubMed ID: 24219981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of comorbidity on the initiation of chemotherapy and survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma.
    Guo R; Mao YP; Chen L; Tang LL; Zhou GQ; Liu LZ; Tian L; Zeng MS; Jia WH; Shao JY; Lin AH; Ma J
    Oncotarget; 2017 Feb; 8(6):10594-10601. PubMed ID: 27070084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of the tumor-stroma ratio in gallbladder cancer.
    Li H; Yuan SL; Han ZZ; Huang J; Cui L; Jiang CQ; Zhang Y
    Neoplasma; 2017; 64(4):588-593. PubMed ID: 28485165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
    Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
    Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Tumor-associated Stroma in Nasopharyngeal Carcinoma: A Multicenter Study.
    Almangush A; Ruuskanen M; Hagström J; Kosma VM; Nieminen P; Mäkitie AA; Leivo I
    Am J Surg Pathol; 2024 Jan; 48(1):54-58. PubMed ID: 37779503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation.
    Lv Z; Cai X; Weng X; Xiao H; Du C; Cheng J; Zhou L; Xie H; Sun K; Wu J; Zheng S
    Surgery; 2015 Jul; 158(1):142-50. PubMed ID: 25890776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of the Tumor-Stroma Ratio in Epithelial Ovarian Cancer.
    Chen Y; Zhang L; Liu W; Liu X
    Biomed Res Int; 2015; 2015():589301. PubMed ID: 26609529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: analysis of 1301 patients from an endemic area in China.
    Liu X; Li X; Jiang N; Lei Y; Tang LL; Chen L; Zhou GQ; Sun Y; Yue D; Guo R; Mao YP; Li WF; Liu LZ; Tian L; Lin AH; Ma J
    Cancer; 2014 Jan; 120(1):68-76. PubMed ID: 24114075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma: a multivariate analysis of prognostic factors.
    Vlantis AC; Chan HS; Tong MC; Yu BK; Kam MK; van Hasselt CA
    Head Neck; 2011 Aug; 33(8):1126-31. PubMed ID: 21755557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating lymphocytes associate with outcome in nonendemic nasopharyngeal carcinoma: a multicenter study.
    Almangush A; Ruuskanen M; Hagström J; Hirvikoski P; Tommola S; Kosma VM; Nieminen P; Mäkitie A; Leivo I
    Hum Pathol; 2018 Nov; 81():211-219. PubMed ID: 30030117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area.
    Huang PY; Zeng Q; Cao KJ; Guo X; Guo L; Mo HY; Wu PH; Qian CN; Mai HQ; Hong MH
    Eur J Cancer; 2015 Sep; 51(13):1760-70. PubMed ID: 26093812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor-stroma ratio in colon cancer.
    Polack M; Smit MA; van Pelt GW; Roodvoets AGH; Meershoek-Klein Kranenbarg E; Putter H; Gelderblom H; Crobach ASLP; Terpstra V; Petrushevska G; Gašljević G; Kjær-Frifeldt S; de Cuba EMV; Bulkmans NWJ; Vink GR; Al Dieri R; Tollenaar RAEM; van Krieken JHJM; Mesker WE;
    ESMO Open; 2024 Apr; 9(4):102988. PubMed ID: 38613913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis.
    Wu J; Liang C; Chen M; Su W
    Oncotarget; 2016 Oct; 7(42):68954-68965. PubMed ID: 27661111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
    Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
    Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
    Yoon HI; Kim KH; Lee J; Roh YH; Yun M; Cho BC; Lee CG; Keum KC
    Cancer Res Treat; 2016 Jul; 48(3):928-41. PubMed ID: 26693913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.